Article: H.C. Wainwright Starts Ekso Bionics (EKSO) at Buy
H.C. Wainwright Starts Ekso Bionics (EKSO) at Buy StreetInsider.com, 28 October 2019 H.C. Wainwright analyst Swayampakula Ramakanth initiates coverage on Ekso Bionics (NASDAQ: EKSO) with a Buy rating and a price target of $1.20. Read full article. Comment: This appears to be a stellar example of a life-saving vital technology company being destroyed by collusion between a …
Continue reading “Article: H.C. Wainwright Starts Ekso Bionics (EKSO) at Buy”